Novel “Add-On” Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents

One of the major design considerations for a drug is its pharmacokinetics in the blood. A drug with a short half-life in the blood is less available at a target organ. Such a limitation dictates treatment with either high doses or more frequent doses, both of which may increase the likelihood of und...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Nucl Med
Asıl Yazarlar: Chen, Haojun, Jacobson, Orit, Niu, Gang, Weiss, Ido D., Kiesewetter, Dale O., Liu, Yi, Ma, Ying, Wu, Hua, Chen, Xiaoyuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Society of Nuclear Medicine 2017
Konular:
Theranostics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5373503/
https://ncbi.nlm.nih.gov/pubmed/27879373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.116.182097
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller